Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-031570)

Filing Details

Accession Number:: 0001209191-17-031570
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-11 17:01:58
Reporting Period:: 2017-05-09

Filing Date:: 2017-05-11
Accepted Time:: 2017-05-11 17:01:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1689813	Biohaven Pharmaceutical Holding Co Ltd.	BHVN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1704255	James Engelhart	C/O Biohaven Pharmaceuticals, Inc. 234 Church Street New Haven CT 06510	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2017-05-09	2,500	$17.00	3,576	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Reflects common shares purchased under the Issuer's directed share program in connection with the Issuer's initial public offering.